Julie B. Feder
Chief Financial Officer, Verastem Oncology.
Companies
- Obsidian Therapeutics, Inc.Chief financial officer Aug 3, 2026 to now1
- Aura Investments Ltd.Chief financial officer Oct 28, 2021 to Oct 21, 20242
- Verastem OncologyChief financial officer Jul 11, 2017 to Jun 4, 20183
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Aura Investments Ltd. AURA134,276 shares4$845.9K at $6.30Oct 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 18, 2024Sold 25,131 shares at $12.03 of Aura Investments Ltd.4
- Oct 18, 2024Exercised options 5,000 shares at $5.48 of Aura Investments Ltd.4
- Oct 18, 2024Exercised options 2,631 shares at $4.25 of Aura Investments Ltd.4
- Oct 18, 2024Exercised options 17,500 shares at $2.74 of Aura Investments Ltd.4
- Feb 1, 2024Granted 71,285 shares of Aura Investments Ltd.5
- Jan 23, 2024Sold 6,609 shares at $7.64 of Aura Investments Ltd.6
- Nov 6, 2023Sold 3,900 shares at $12.07 of Aura Investments Ltd.7
- Nov 6, 2023Exercised options 3,900 shares at $2.74 of Aura Investments Ltd.7
- Oct 30, 2023Sold 3,385 shares at $6.82 of Aura Investments Ltd.8
- Jan 19, 2023Granted 48,750 shares of Aura Investments Ltd.9
- Oct 31, 2022Sold 2,015 shares at $12.45 of Aura Investments Ltd.10
- Oct 28, 2021Granted 26,250 shares of Aura Investments Ltd.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 2, 2024
- 6SEC EDGARForm 4 filed Jan 24, 2024
- 7SEC EDGARForm 4 filed Nov 7, 2023
- 8SEC EDGARForm 4 filed Nov 1, 2023
- 9SEC EDGARForm 4 filed Jan 23, 2023
- 10SEC EDGARForm 4 filed Nov 2, 2022
- 11SEC EDGARForm 4 filed Oct 29, 2021